Rebiogen Co., Ltd – Trademark Portfolio

Entity Type: 03

Rebiogen Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DOGSIGNAL.

A Dong 1421Ho, 1422Ho (Yeongcheon-dong, Dongtan Silicon Alley),

150, Dongtanyeongcheon-ro, Hwaseong-si Gyeonggi-do 18462

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DOGSIGNAL
DOGSIGNAL
Registered 2025

Trademark Classifications

Rebiogen Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Rebiogen Co., Ltd have?

Rebiogen Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Rebiogen Co., Ltd file in?

Rebiogen Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Rebiogen Co., Ltd's most well-known trademarks?

Rebiogen Co., Ltd's registered trademark portfolio includes well-known marks such as DOGSIGNAL. These are among 1 currently registered trademark in the portfolio.

What is Rebiogen Co., Ltd's trademark registration success rate?

Rebiogen Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.